212 related articles for article (PubMed ID: 32216084)
1. Population and Noncompartmental Pharmacokinetics of Sodium Oxybate Support Weight-Based Dosing in Children and Adolescents With Narcolepsy With Cataplexy.
Chen C; Rosen CL; Ruoff C; Boyce LH; Parvataneni R; Zomorodi K; Brantley S; Sale M; Plazzi G
Clin Transl Sci; 2020 Sep; 13(5):932-940. PubMed ID: 32216084
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
Lecendreux M; Plazzi G; Dauvilliers Y; Rosen CL; Ruoff C; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
J Clin Sleep Med; 2022 Sep; 18(9):2217-2227. PubMed ID: 35689598
[TBL] [Abstract][Full Text] [Related]
3. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
Dauvilliers Y; Šonka K; Bogan RK; Partinen M; Del Rio Villegas R; Foldvary-Schaefer N; Skowronski R; Chen A; Black J; Skobieranda F; Thorpy MJ
CNS Drugs; 2022 Jun; 36(6):633-647. PubMed ID: 35635687
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
Bogan RK; Foldvary-Schaefer N; Skowronski R; Chen A; Thorpy MJ
CNS Drugs; 2023 Apr; 37(4):323-335. PubMed ID: 36947322
[TBL] [Abstract][Full Text] [Related]
5. Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.
Roth T; Thorpy MJ; Kushida CA; Horsnell M; Gudeman J
J Comp Eff Res; 2023 Dec; 12(12):e230133. PubMed ID: 37971303
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium oxybate on body mass index in pediatric patients with narcolepsy.
Dauvilliers Y; Lammers GJ; Lecendreux M; Maski K; Kansagra S; Black J; Parvataneni R; Chen A; Wang YG; Plazzi G
J Clin Sleep Med; 2024 Mar; 20(3):445-454. PubMed ID: 37942930
[TBL] [Abstract][Full Text] [Related]
7. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, bioavailability, and bioequivalence of lower-sodium oxybate in healthy participants in two open-label, randomized, crossover studies.
Chen C; Jenkins J; Zomorodi K; Skowronski R
Clin Transl Sci; 2021 Nov; 14(6):2278-2287. PubMed ID: 34121333
[TBL] [Abstract][Full Text] [Related]
9. Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
Rosenberg R; Braceras R; Macfadden W; Candler S; Black J; Ruoff C
Neurol Ther; 2023 Dec; 12(6):1805-1820. PubMed ID: 37755650
[TBL] [Abstract][Full Text] [Related]
10. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
[TBL] [Abstract][Full Text] [Related]
11. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
Black J; Swick T; Bogan R; Lai C; Carter LP
Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
[TBL] [Abstract][Full Text] [Related]
12. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
[TBL] [Abstract][Full Text] [Related]
13. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
Kushida CA; Shapiro CM; Roth T; Thorpy MJ; Corser BC; Ajayi AO; Rosenberg R; Roy A; Seiden D; Dubow J; Dauvilliers Y
Sleep; 2022 Jun; 45(6):. PubMed ID: 34358324
[TBL] [Abstract][Full Text] [Related]
14. Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers.
Bogan R; Thorpy MJ; Winkelman JW; Dubow J; Gudeman J; Seiden D
Sleep Med; 2022 Dec; 100():442-447. PubMed ID: 36252412
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) questionnaire in pediatric patients with narcolepsy with cataplexy aged 7-16 years.
Wang YG; Menno D; Chen A; Steininger TL; Morris S; Black J; Profant J; Johns MW
Sleep Med; 2022 Jan; 89():78-84. PubMed ID: 34920345
[TBL] [Abstract][Full Text] [Related]
16. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis.
Alshaikh MK; Tricco AC; Tashkandi M; Mamdani M; Straus SE; BaHammam AS
J Clin Sleep Med; 2012 Aug; 8(4):451-8. PubMed ID: 22893778
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy.
Bogan RK; Thorpy MJ; Dauvilliers Y; Partinen M; Del Rio Villegas R; Foldvary-Schaefer N; Skowronski R; Tang L; Skobieranda F; Šonka K
Sleep; 2021 Mar; 44(3):. PubMed ID: 33184650
[TBL] [Abstract][Full Text] [Related]
18. Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.
Junnarkar G; Allphin C; Profant J; Steininger TL; Chen C; Zomorodi K; Skowronski R; Black J
Expert Opin Drug Discov; 2022 Feb; 17(2):109-119. PubMed ID: 34818123
[TBL] [Abstract][Full Text] [Related]
19. A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy.
Mamelak M; Swick T; Emsellem H; Montplaisir J; Lai C; Black J
Sleep Med; 2015 Jan; 16(1):52-8. PubMed ID: 25533539
[TBL] [Abstract][Full Text] [Related]
20. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
Bogan RK; Roth T; Schwartz J; Miloslavsky M
J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
